Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
Study NCT ID:
NCT07233720
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2025-07-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Sponsor:
Henan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-08
First Submit QC Date:
None
Study First Post Date:
2025-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-16
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED